Rigel Pharmaceuticals | RIGL - Zobowiązania Handlowe





Zobowiązania Handlowe Zmiana Data
Agenus USD 71.08M 11.9M 2026-03
Amgen USD 19.52B 1.37B 2026-03
Anika Therapeutics USD 6.34M 298K 2026-03
Arrowhead Research USD 30.75M 2.19M 2026-03
AstraZeneca USD 22.51B 2.78B 2026-03
BioMarin Pharmaceutical USD 793.15M 34.12M 2026-03
Bristol-Myers Squibb USD 4.23B 659M 2026-03
Celldex Therapeutics USD 10.36M 9.18M 2026-03
Daiichi Sankyo JPY 568.5B 16.84B 2025-12
Eli Lilly USD 5.03B 350M 2026-03
Halozyme Therapeutics USD 14.1M 6.8M 2026-03
Heron Therapeutics USD 8.97M 24K 2026-03
Intrexon USD 4.85M 3.12M 2024-06
Ionis Pharmaceuticals USD 26.03M 2.05M 2026-03
Karyopharm Therapeutics USD 4M 1.39M 2025-12
Ligand Pharmaceuticals USD 37.11M 33.87M 2026-03
MacroGenics USD 4.29M 500K 2026-03
Neurocrine Biosciences USD 691.3M 145.8M 2026-03
Pfizer USD 4.51B 734M 2026-03
Regeneron Pharmaceuticals USD 1.03B 4.81B 2026-03
Rigel Pharmaceuticals USD 3.85M 3.44M 2025-09
Sangamo BioSciences USD 10.74M 7.46M 2025-06
Ultragenyx Pharmaceutical USD 42M 11M 2026-03
Veracyte USD 6.91M 2.32M 2026-03